What are the guidelines for performing endoscopic gastric fundoplication in adult patients with chronic gastro‑oesophageal reflux disease who have persistent symptoms despite optimized proton‑pump inhibitor therapy, abnormal acid exposure on pH monitoring, and a small (<2 cm) hiatal hernia without severe esophagitis or Barrett’s segment longer than 2 cm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Endoscopic Gastric Fundoplication Guidelines

For adult patients with chronic GERD who have persistent symptoms despite optimized PPI therapy, abnormal acid exposure on pH monitoring, and a small (<2 cm) hiatal hernia without severe esophagitis or Barrett's segment longer than 2 cm, transoral incisionless fundoplication (TIF) is suggested as an alternative to chronic medical management or surgical fundoplication. 1

Patient Selection Criteria

The most recent ASGE guideline (2025) provides specific criteria for endoscopic fundoplication candidacy 1:

  • Confirmed GERD with objective evidence (abnormal pH monitoring)
  • Small hiatal hernias ≤2 cm
  • Hill grade I or II gastroesophageal junction integrity
  • Predominant heartburn symptoms (rather than regurgitation)
  • Persistent troublesome symptoms despite PPI therapy
  • Absence of severe esophagitis (your patient meets this)
  • Barrett's segment ≤2 cm (your patient meets this)

Your patient profile matches these criteria precisely, making them an appropriate candidate for TIF evaluation.

Contraindications and Exclusions

Patients who should not undergo endoscopic fundoplication include those with:

  • Large hiatal hernias >2 cm (should be referred for combined TIF with hiatal hernia repair [cTIF] or surgical therapy) 1
  • Hill grade III or IV gastroesophageal junction disruption 1
  • Predominant regurgitation symptoms (surgery may be more appropriate) 2
  • Severe esophagitis at baseline 3

Treatment Algorithm

Step 1: Optimize Medical Therapy First

  • Maximize PPI dosing and duration
  • Confirm medication compliance
  • Trial lifestyle modifications 1

Step 2: Objective Confirmation Required

  • pH monitoring to document abnormal acid exposure (your patient has this)
  • Upper endoscopy to assess hiatal hernia size, Hill grade, esophagitis severity, and Barrett's length 1
  • Document specific anatomic findings with photo-documentation 1

Step 3: Stratify by Hiatal Hernia Size and Hill Grade

For hiatal hernia ≤2 cm AND Hill grade I-II:

  • Consider TIF as alternative to chronic PPI or surgery 1
  • Discuss risks, benefits, and durability concerns with patient

For hiatal hernia >2 cm OR Hill grade III-IV:

  • Refer for cTIF or surgical fundoplication based on multidisciplinary review 1
  • Standard laparoscopic Nissen fundoplication remains gold standard 2, 4

Evidence Quality and Limitations

Historical Context (2006-2008)

Earlier AGA guidelines were highly skeptical of endoscopic therapies, stating "there are no definite indications for endoscopic therapy for GERD at this time" 3. This was based on:

  • Modest effects on LES pressure and acid exposure
  • High sham response rates in trials
  • Safety concerns (Enteryx withdrawn in 2005) 3
  • Insufficient evidence of durability beyond 1-2 years 3

The 2008 AGA guideline gave endoluminal procedures a Grade Insufficient recommendation due to lack of evidence 2.

Current Evidence (2025)

The landscape has evolved significantly. The 2025 ASGE guideline now suggests TIF for appropriately selected patients 1, reflecting:

  • Improved device technology (particularly TIF 2.0)
  • Better patient selection criteria
  • Accumulating safety and efficacy data
  • Recognition that TIF addresses a treatment gap between medical therapy and surgery

Critical caveat: This is still a "suggests" rather than "recommends" strength recommendation, indicating moderate rather than high-quality evidence 1.

Practical Considerations

Advantages of TIF Over Surgery

  • Outpatient procedure 3
  • Lower risk profile than fundoplication 5
  • Potentially fewer postoperative side effects (dysphagia, gas-bloat, inability to belch) 2
  • Preserves future surgical options if needed

Limitations of TIF

  • Durability concerns remain—long-term data beyond 5-10 years are limited 3, 5
  • Less effective than surgery for severe anatomic disruption 1
  • May not normalize acid exposure in all patients 3
  • Requires expertise at specialized centers 6
  • Not appropriate for predominant regurgitation symptoms 2

Common Pitfalls to Avoid

  1. Performing TIF without objective GERD confirmation: Always document abnormal pH monitoring before proceeding 1

  2. Ignoring hiatal hernia size: Hernias >2 cm require surgical repair, not TIF alone 1

  3. Overlooking Hill grade: Grade III-IV indicates significant anatomic disruption requiring more robust repair 1

  4. Using TIF for PPI-responsive patients who tolerate medication well: This is explicitly not recommended—save intervention for PPI failures or intolerant patients 2

  5. Expecting TIF to prevent cancer in Barrett's esophagus: Antireflux procedures (surgical or endoscopic) are not recommended as antineoplastic measures 2

Alternative Endoscopic Options

While TIF has the strongest evidence base, other endoscopic approaches exist 6:

  • Radiofrequency energy delivery: Insufficient evidence for routine use in PPI nonresponders 5
  • Anti-reflux mucosal interventions (ARMI): Still investigational 6
  • Magnetic sphincter augmentation: Surgical rather than endoscopic, but less invasive than fundoplication 5

For your specific patient, TIF is the only endoscopic option with guideline support given their anatomic profile 1.

When to Choose Surgery Instead

Laparoscopic fundoplication should be prioritized over TIF when 2, 4:

  • Patient has predominant regurgitation rather than heartburn
  • Large hiatal hernia (>2 cm) present
  • Hill grade III or IV disruption
  • Patient desires most durable long-term solution with proven 10+ year data
  • Patient willing to accept higher risk of postoperative dysphagia and gas-bloat syndrome

The 2008 AGA guideline emphasizes that when PPI and surgery offer similar efficacy, PPI should be initial therapy due to superior safety 2. However, for PPI failures or intolerant patients, both surgery and now TIF (in selected cases) are reasonable alternatives.

Related Questions

What is the most effective proton pump inhibitor (PPI) for acid suppression in adults with gastro‑oesophageal reflux disease?
I have bloating, stomach discomfort, sour stomach, and dizziness despite being diagnosed with gastroesophageal reflux disease (GERD), hiatal hernia, and stage 1 Barrett’s esophagus, and having taken vonoprazan (voquezna) for six months with occasional flare‑ups and intermittent Gaviscon (alginate) use; what management steps should I take?
Can gastro‑oesophageal reflux disease (GERD) cause stomach pain?
Can a hiatal hernia irritate the vagus nerve?
In a 35-year-old patient with epigastric pain and signs of gastroesophageal reflux disease (GERD) who reports dark (coffee‑ground) emesis, should an abdominal CT scan be performed?
In a woman in her late 80s with a cephalexin allergy and a creatinine clearance of 25–29 mL/min, who has a urine culture growing 10–15 × 10³ CFU/mL Pseudomonas aeruginosa susceptible to aztreonam, cefepime, ceftazidime, ciprofloxacin, levofloxacin, meropenem, piperacillin‑tazobactam, and tobramycin, should she be treated?
Which oil is recommended for a patient with dyslipidemia?
How many days does it take for edoxaban (direct oral factor Xa inhibitor) to achieve its anticoagulant effect, and can its plasma level be measured?
Can a patient be treated with desvenlafaxine (Pristiq) 50 mg and fluoxetine (Prozac) 10 mg concurrently for excoriation (skin‑picking)?
What is the differential diagnosis and recommended evaluation for a 37-year-old female with low BUN, low serum albumin, and a low anion‑gap ratio?
What can be added to desvenlafaxine (Pristiq) to help with skin‑picking (excoriation disorder) while the patient is already on 50 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.